IN BRIEF: Oxford Nanopore signs deal with PathoQuest to develop test
Oxford Nanopore Technologies PLC - Oxford, England-based company that develops and sells nanopore sequencing products - Signs a definitive deal with PathoQuest SAS to co-develop an 'integration site analysis' test. Says the test will provide a good manufacturing practice validated nanopore sequencing-based commercial testing service to the biopharma industry. Oxford Nanopore says the service is designed to address the needs of industrial developers and manufacturers of biological products. Read More